随着社会老年化的加重，心力衰竭的发病率和死亡率逐渐增加，因此，关于各种心力衰竭的 治疗方法受到全球的广泛重视，同时，关于心力衰竭的治疗方法也在不断的取得新的进展，各国的心力衰 竭指南也在不断的更新。目前，血管紧张素受体脑啡肽酶抑制剂、钠葡萄糖共转运蛋白 2 抑制剂、可溶性 鸟苷酸环化酶（sGC）激活剂、铁剂、重组人松弛素 ⁃2 以及心脏康复治疗等已被证实可以使心力衰竭患者 获益，本文将对心力衰竭的治疗进展进行总结，以期为临床治疗提供参考。

With the aggravation of social aging，the morbidity and mortality of heart failure are gradually increasing. Therefore，more and more attention has been paid to diverse therapies for the treatment of heart failure all over the world. At the same time，new progress has been made in the treatment of heart failure，and the guidelines for heart failure have also been constantly updated in many countries. At present，angiotensin receptor enkephalin inhibitors，sodium and glucose cotransporter 2 inhibitors，soluble guanylatecyclase activators，iron supplements， recombinant human relaxin⁃2 and cardiac rehabilitation have been proved to benefit patients with heart failure. This article will review the progress in the treatment of heart failure in order to provide reference for clinical treatment.